Literature DB >> 1404598

Induction of E1A-responsive negative factors for transcription of the fibronectin gene in adenovirus E1-transformed rat cells.

T Nakamura1, T Nakajima, S Tsunoda, S Nakada, K Oda, H Tsurui, A Wada.   

Abstract

The level of fibronectin (FN) gene expression is very high in resting rat 3Y1 cells but greatly decreased in adenovirus E1-transformed cells. To study the mechanism of this down-regulation, nuclear factors binding to the 5'-flanking region of the FN gene were analyzed by gel retardation assay and DNase I footprinting. Nuclear factors that were present in the transformed cells but nearly absent in resting 3Y1 cells interacted with multiple sites of the promoter region. Oligonucleotide competition with the FN promoter-chloramphenicol acetyltransferase (CAT) reporter constructs (pFCAT) for these factors in the transformed cells indicated that all of them had a negative effect on FN gene expression. Of them, a factor(s) (G10BP) binding to the G10 stretch from positions -239 to -230 and to two GC boxes consisting of the G10 stretch with one internal C residue insertion from positions -105 to -95 and -54 to -44 had the strongest repressive activity. Introduction of substitutive mutations into these G-rich sequences resulted in the increase in CAT activity of pFCAT in the transformed cells. The recognition sequences of G10BP and Sp1 overlap in two GC boxes. G10BP has stronger affinity for heparin and GC boxes than does Sp1, suggesting that G10BP may repress FN gene transcription by displacing Sp1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1404598      PMCID: PMC240136     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Adenovirus E1a proteins repress transcription from the SV40 early promoter.

Authors:  A Velcich; E Ziff
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

2.  An exonuclease protection assay reveals heat-shock element and TATA box DNA-binding proteins in crude nuclear extracts.

Authors:  C Wu
Journal:  Nature       Date:  1985 Sep 5-11       Impact factor: 49.962

3.  An anticatalytic monoclonal antibody to avian plasminogen activator: its effect on behavior of RSV-transformed chick fibroblasts.

Authors:  L M Sullivan; J P Quigley
Journal:  Cell       Date:  1986-06-20       Impact factor: 41.582

Review 4.  Integrins: a family of cell surface receptors.

Authors:  R O Hynes
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

5.  Adenovirus E1A coding sequences that enable ras and pmt oncogenes to transform cultured primary cells.

Authors:  B Zerler; B Moran; K Maruyama; J Moomaw; T Grodzicker; H E Ruley
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

6.  Purification and biochemical characterization of the promoter-specific transcription factor, Sp1.

Authors:  M R Briggs; J T Kadonaga; S P Bell; R Tjian
Journal:  Science       Date:  1986-10-03       Impact factor: 47.728

7.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product.

Authors:  P Whyte; K J Buchkovich; J M Horowitz; S H Friend; M Raybuck; R A Weinberg; E Harlow
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

8.  Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis.

Authors:  M Fried; D M Crothers
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

9.  Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain.

Authors:  J T Kadonaga; K R Carner; F R Masiarz; R Tjian
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

10.  Different activities of the adenovirus types 5 and 12 E1A regions in transformation with the EJ Ha-ras oncogene.

Authors:  A G Jochemsen; R Bernards; H J van Kranen; A Houweling; J L Bos; A J van der Eb
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

View more
  9 in total

1.  DNA binding proteins from keloid fibroblasts form unique complexes with the human fibronectin promoter.

Authors:  J C Sible; E Eriksson; N Oliver
Journal:  Gene Expr       Date:  1996

2.  Induction of Sp1 in differentiating human embryonal carcinoma cells triggers transcription of the fibronectin gene.

Authors:  M Suzuki; E Oda; T Nakajima; S Sekiya; K Oda
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

3.  Human papillomavirus type 16 E7 oncoprotein represses transcription of human fibronectin.

Authors:  O Rey; S Lee; N H Park
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  KSHV regulation of fibulin-2 in Kaposi's sarcoma: implications for tumorigenesis.

Authors:  Donald J Alcendor; Susan Knobel; Prashant Desai; Wen Qui Zhu; Gary S Hayward
Journal:  Am J Pathol       Date:  2011-07-07       Impact factor: 4.307

5.  Transcription factor TFIID is a direct functional target of the adenovirus E1A transcription-repression domain.

Authors:  C Z Song; P M Loewenstein; K Toth; M Green
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

6.  Sp1-mediated transactivation of LamC1 promoter and coordinated expression of laminin-gamma1 and Sp1 in human hepatocellular carcinomas.

Authors:  J Liétard; O Musso; N Théret; A L'Helgoualc'h; J P Campion; Y Yamada; B Clément
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

7.  G10BP, an E1A-inducible negative regulator of Sp1, represses transcription of the rat fibronectin gene.

Authors:  M Suzuki; C Kuroda; E Oda; S Tsunoda; T Nakamura; T Nakajima; K Oda
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

8.  Cloning and characterization of a GC-box binding protein, G10BP-1, responsible for repression of the rat fibronectin gene.

Authors:  E Oda; K Shirasuna; M Suzuki; K Nakano; T Nakajima; K Oda
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

9.  Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II.

Authors:  Ka C Lee; Rebecca L Bramley; Ian G Cowell; Graham H Jackson; Caroline A Austin
Journal:  Biochem Pharmacol       Date:  2016-01-12       Impact factor: 5.858

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.